Study shows PET can measure effectiveness of novel breast cancer treatment
Thursday, July 2, 2009 - 07:56
in Health & Medicine
A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended. Researchers successfully used PET and a specially-developed radioactive compound to image HER2 - a protein often associated with aggressive breast cancer - in breast cancer cells before and after treatment aimed at decreasing HER2 expression...
Read the whole article on Science Centric
More from Science Centric
Related
- Study shows PET can measure effectiveness of novel breast cancer treatmentThu, 2 Jul 2009, 8:45:06 EDT
- HER2 levels may aid in treatment selection for metastatic breast cancerTue, 2 Dec 2008, 10:49:47 EST
- New possibilities for breast cancer treatment on the horizonMon, 16 Jun 2008, 12:49:39 EDT
- Protein predicts development of invasive breast cancer in women with DCIS, Penn study showsFri, 22 May 2009, 9:09:25 EDT
- Vaccine against HER2-positive breast cancer offers complete protection in labMon, 15 Sep 2008, 5:36:14 EDT